United Kingdom: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

The Right To Choose: A Faster Path To Autism And ADHD Diagnosis For Children? (5 June 2025)

When it is suspected that a child may have autism or ADHD, a specialist assessment is needed to confirm a diagnosis. In the case of autism this must be a multi-disciplinary assessment.

United Kingdom Healthcare

DL

Duncan Lewis & Co Solicitors

Food Packaging And Sustainable Packaging

As part of efforts to improve sustainability in the supply chain, smart packaging is a hot topic in a number of consumer industries, but no more so than in the food and beverage space.

United Kingdom Healthcare

B

Boult Wade Tennant

Reforming The Hair Strand Testing Industry - Why Expert Interpretation Matters (21 May 2025)

For years, the family court system has relied heavily on simplified drug and alcohol test results.

United Kingdom Healthcare

DL

Duncan Lewis & Co Solicitors

Looking To The Future - UK Biotech In 2035

The bioindustry association (BIA) have issued a new report setting out their vision for UK biotech in 2035. The headline approach is that there needs to be a "shift in mindset" to unlock the UK's full potential.

United Kingdom Healthcare

MC

Marks & Clerk

The EU Biotech Act Has Been Delayed — Here's What That Means

European Union Healthcare

AP

Arnold & Porter

Empowering The Future Of Grocery: AlixPartners' Role In Strengthening The WAFC's Mission And Reach

United Kingdom Healthcare

A

AlixPartners

Recent Updates On Reform Of UK Clinical Trial Landscape

United Kingdom Healthcare

AP

Arnold & Porter

Understanding The Latest OPG Guidance On Family Care Payments

United Kingdom Healthcare

WS

Wrigleys Solicitors

Cacao-free Chocolate - A Taste Of The Future?

United Kingdom Healthcare

MC

Marks & Clerk

Health Data Research Service To Provide Single Point Of Access To NHS Data In The United Kingdom

United Kingdom Healthcare

AO

A&O Shearman

Repeated Failures In Scan Interpretation Is Costing Lives, Ombudsman Warns (9 April 2025)

United Kingdom Healthcare

DL

Duncan Lewis & Co Solicitors

Insights To Patent Drafting For Food And Beverage Innovations

Worldwide Healthcare

B

Boult Wade Tennant

Future R&D Funding In The UK

United Kingdom Healthcare

MC

Marks & Clerk

A New Approach To Regulation By The MHRA And NICE

United Kingdom Healthcare

AO

A&O Shearman

Third Party Rights – Welcome Guidance From The High Court

United Kingdom Real Estate

BC

Bryan Cave Leighton Paisner

What Every Commercial Landlord Needs To Know About Tenant Lease Breaches

United Kingdom Real Estate

RF

Ronald Fletcher Baker

TUPE Takeaways: Do All Liabilities Transfer Under TUPE?

United Kingdom Employment

LS

Lewis Silkin

Electronic Travel Authorisation: How We Can Help

United Kingdom Immigration

IL

Ius Laboris

GLP-1: Implications For Retail (Video)

United Kingdom Consumer

A

AlixPartners

Food and Drugs Law

POMs, OTCs And The ASA: A Look At The Latest Ruling

The Advertising Standards Authority (ASA) has upheld a ruling that serves as a timely reminder to all advertisers...

United Kingdom Media & IT

LS

Lewis Silkin

New Antibiotics - Cautious Optimism

We recently reported (here) on the global challenge of antimicrobial resistance (AMR) and discussed how antimicrobial patent filings have faired over the last 10 years.

United Kingdom IP

MC

Marks & Clerk

Advertising Foods High In Fat, Sugar Or Salt (HFSS)

Advertising of less healthy foods (or foods high in fat, sugar and/or salt) is under a lot of scrutiny in the UK due to the obesity crisis. Advertising HFSS products is already tightly regulated in the UK...

United Kingdom Media & IT

LS

Lewis Silkin

Digging Deep To Avoid Scratching The Surface: The Quest For Non-Invasive Glucose Monitoring Solutions Continues

United Kingdom IP

MC

Marks & Clerk

IP Ingredients: What Will The EU's Design Reform Package Do For Food & Drink Businesses?

United Kingdom IP

HL

HGF Ltd

New Antibiotics - Cautious Optimism

United Kingdom IP

MC

Marks & Clerk

Food Packaging And Sustainable Packaging

United Kingdom Healthcare

B

Boult Wade Tennant

Andy Searle, EMEA Leader Of Consumer Products, Comments On The ONS' Consumer Price Inflation Data

United Kingdom Consumer

A

AlixPartners

What Does The UK-EU "Re-Set" Mean For Business?

United Kingdom International

TS

Travers Smith LLP

See more

Life Sciences, Biotechnology & Nanotechnology

Looking To The Future - UK Biotech In 2035

The bioindustry association (BIA) have issued a new report setting out their vision for UK biotech in 2035. The headline approach is that there needs to be a "shift in mindset" to unlock the UK's full potential.

United Kingdom Healthcare

MC

Marks & Clerk

The EU Biotech Act Has Been Delayed — Here's What That Means

The current EU regulatory landscape for biotechnology is widely viewed as insufficient to be able to exploit the full potential of such technologies.

European Union Healthcare

AP

Arnold & Porter

£13.9bn Of R&D Funding

The UK government has announced a record-breaking £13.9 billion in research and development (R&D) funding for the coming year.

United Kingdom Strategy

IG

IR Global

The Effect Of The Unified Patent Court (UPC) On Opposition Proceedings At The European Patent Office (EPO)

United Kingdom IP

KL

Keltie LLP

Global Insights: Patent Protection For Polymorphs

B

Boult Wade Tennant

Recent Updates On Reform Of UK Clinical Trial Landscape

United Kingdom Healthcare

AP

Arnold & Porter

Blueprints For Growth: Perspectives On Life Sciences & Innovation Investments

United Kingdom Real Estate

AG

Addleshaw Goddard

Future R&D Funding In The UK

United Kingdom Healthcare

MC

Marks & Clerk

Going Down The Bio-Produced Silk Road

United Kingdom IP

MC

Marks & Clerk

See more

Healthcare

POMs, OTCs And The ASA: A Look At The Latest Ruling

The Advertising Standards Authority (ASA) has upheld a ruling that serves as a timely reminder to all advertisers...

United Kingdom Media & IT

LS

Lewis Silkin

Artificial Intelligence And Women's Health

Artificial Intelligence (AI) has the potential to revolutionise women's health in a time of increased awareness of health inequality. In the UK, the National Health Service (NHS)...

United Kingdom IP

MC

Marks & Clerk

The Right To Choose: A Faster Path To Autism And ADHD Diagnosis For Children? (5 June 2025)

When it is suspected that a child may have autism or ADHD, a specialist assessment is needed to confirm a diagnosis. In the case of autism this must be a multi-disciplinary assessment.

United Kingdom Healthcare

DL

Duncan Lewis & Co Solicitors

National Rollout Of ABC Programme A Welcome Development Urgently Needed For NHS Maternity Care

United Kingdom Litigation

HL

Higgs LLP

Got An Early Dementia Diagnosis? Protect Your Interests Today

United Kingdom Family

RB

Rothera Bray

Supporting Life-Changing Work: Hats For Headway And Spinal Injury Association Awareness Day

United Kingdom Litigation

HL

Higgs LLP

Can I Be Sacked For Working A Second Job Whilst I'm Off Sick?

United Kingdom Employment

RB

Rothera Bray

Looking To The Future - UK Biotech In 2035

United Kingdom Healthcare

MC

Marks & Clerk

£13.9bn Of R&D Funding

United Kingdom Strategy

IG

IR Global

See more

Patents

Supplementary Protection Certificates: The Court Of Justice Agrees With Potter Clarkson That SPCs With Negative Terms Are Acceptable

The Court of Justice of the European Union (CJEU) ruled yesterday in an important case (C-125/10, Merck Sharp & Dohme Corp. v Deutsches Patent- und Markenamt), relating to Supplementary Protection Certificates (SPCs).

European Union IP

PC

Potter Clarkson

Value Added SPCs - CJEU Clarifies Broad Scope Of Protection

Following hot on the heels of important SPC decisions issued in late 2011, the Court of Justice of the European Union (CJEU) has now issued a reasoned order in the Novartis v Actavis case (C-442/11).

European Union IP

PC

Potter Clarkson

Supplementary Protection Certificates: The CJEU Issues Its Decision In Two Seminal Cases

On 24 November 2011, the Court of Justice of the European Union (CJEU) delivered its judgement in two seminal cases relating to Supplementary Protection Certificates (SPCs).

European Union IP

PC

Potter Clarkson

HGS v Eli Lilly: Bar For Industrial Applicability Of Gene Patents In UK Lowered And Realigned With The EPO

United Kingdom Healthcare

PC

Potter Clarkson

Pharmaceutical Patent Settlement Agreements - European Commission Scrutiny Continues

United Kingdom IP

CC

CMS Cameron McKenna Nabarro Olswang

You Never Give Me Your Money: Competition Law, Damages Actions, And The Healthcare Sector

United Kingdom Anti-trust

TW

Taylor Wessing

Generic Opportunities Arising For The Blockbuster Antihypertensive, Diovan® (Valsartan)

United Kingdom Healthcare

GW

Generics Web

EU/UK Competition Law Newsletter - February 2011

United Kingdom Anti-trust

ML

McGuireWoods LLP

Reform Of Corporation Tax For Lifesciences Companies - A Chance To Have Your Say

United Kingdom Tax

CC

CMS Cameron McKenna Nabarro Olswang

See more

Latest Videos

See more

Working For And With The European Medicines Agency (EMA) (Video)

AP

Arnold & Porter

Episode #1: Hugo Scheckter - Player Care: The Importance Of Mental Health And Wellbeing In Football (Video)

BM

Blaser Mills

J2J Clinical Negligence Webinar: Session 3 – What Do You Need To Prove – Breach Of Duty (Video)

GC

Gatehouse Chambers

Osseointegration For Amputees (Video)

B

BLM

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More